
Trump to sign order requiring universities to disclose admissions data
White House Press Secretary Karoline Leavitt confirmed the news in a post on the social media platform X, reposting an article from the right-wing publication The Daily Caller.
Trump has long sought to exert greater control over the country's higher education system, which he and other prominent Republicans consider ideologically skewed.
At the same time, Trump has also sought to dismantle initiatives to promote diversity, equity and inclusion — goals known collectively by the acronym DEI — on the basis that such efforts are inherently discriminatory.
Rolling back DEI
This was such a priority for Trump that, on January 20, during the first day of his second term, he signed an executive order titled 'Ending Radical And Wasteful Government DEI Programs And Preferencing'.
That order repealed a previous directive, issued under President Joe Biden, to advance 'racial equity' and better support 'underserved communities'.
It also called diversity initiatives 'illegal and immoral' and ordered the termination of any such programmes run by the federal government.
'Federal employment practices, including Federal employee performance reviews, shall reward individual initiative, skills, performance, and hard work and shall not under any circumstances consider DEI,' the order explained.
Trump has sought to extend his campaign against DEI beyond the auspices of the federal government, including to private enterprises.
In the immediate aftermath of Trump's inauguration, major US companies like the retailer Target and the carmaker Ford have reframed or dialled back their DEI programming, in an apparent response to the president's platform.
But critics have questioned whether Trump may be exceeding his constitutionally mandated powers.
Some have argued that an embrace of diversity practices falls well within a private enterprise's free speech rights under the First Amendment of the Constitution.
They also point out that, without proactively supporting diversity in companies and universities, those institutions are likely to maintain imbalances in race, gender and ability that do not reflect the wider public.
That, in turn, keeps certain groups out of positions of power, perpetuating a history of segregation and bias in the US.
Peeling back affirmative action
But Trump and his allies have long argued that diversity-promoting practices use race, gender and other factors to discriminate against qualified candidates who may belong to over-represented groups.
In a subsequent executive order on January 21, Trump pledged to restore 'merit-based opportunity' in the US.
'Hardworking Americans who deserve a shot at the American Dream should not be stigmatized, demeaned, or shut out of opportunities because of their race or sex,' the executive order said.
Under Trump, the Department of Education has taken steps to roll back diversity initiatives and other 'divisive ideology' in schools, including by freezing federal funds to institutions that do not comply.
That has put it at loggerheads with academic freedom advocates, who fear the independence of US schools is being trampled in favour of advancing a political agenda.
Opponents of diversity initiatives, however, have won significant victories, most recently in 2023.
That year, the US Supreme Court ruled that affirmative action — the practice of considering race and other diversity factors in school admissions — violated the US Constitution's Fourteenth Amendment, which asserts the right to equal protection under the law.
That decision, delivered by the court's conservative supermajority, overturned decades of precedent and barred schools from using race as a factor for choosing students.
Some conservative groups, however, have continued to question whether there is a bias in school admissions against white, male and Asian students.
Trump versus the Ivy League
The US president has been among the sceptics clamouring for more information about university admissions and hiring practices, and he has made that demand a pillar in his fights with various top schools.
Trump has yanked billions in federal contracts, grants and other funds from schools, including Columbia University in New York, Harvard University in Massachusetts and the University of California, Los Angeles (UCLA), which reported this week a pause on $584m in grants.
To restore those suspended funds, Trump has called on university leaders to agree to his demands, including oversight over admissions.
Columbia was the first major campus to do so. As part of its deal with the Trump administration, Columbia agreed to review its admissions practices and establish an advisory group to 'analyze recent trends in enrollment'.
The advisory group will then 'report to the President', according to the deal.
The Trump administration has also launched federal investigations into universities, alleging violations of civil rights law. Some universities have submitted to Trump's demands in part to bring those probes to a close.
On July 30, for instance, another Ivy League school, Brown University in Rhode Island, announced it had struck a deal in exchange for the continuation of its federal funding and a 'permanent closure' to the 'open reviews and investigations' the Trump administration had launched.
As part of the deal, however, Brown agreed to spend $50m on workforce development programmes and maintain 'merit-based admissions policies'.
'No proxy for racial admission will be tolerated,' the deal reads. 'Brown may not use personal statements, diversity narratives, or any applicant reference to racial identity as a means to introduce or justify discrimination.'
Still, some schools have resisted Trump's demands, most notably Harvard, the nation's oldest university.
In April, Harvard President Alan Garber rejected an agreement proposed by the Trump administration, which would have required a 'comprehensive audit' of the school's hiring and admissions practices.
That data would have then been shared with the federal government.
'No government — regardless of which party is in power — should dictate what private universities can teach, whom they can admit and hire, and which areas of study and inquiry they can pursue,' Garber wrote at the time.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Al Jazeera
2 hours ago
- Al Jazeera
Iran rejects planned transit corridor outlined in Armenia-Azerbaijan pact
Iran has said it will block a corridor planned in the Caucasus under a United States-brokered peace accord between Azerbaijan and Armenia, which has been hailed by other countries in the region as beneficial for achieving lasting peace. Ali Akbar Velayati, a top adviser to Iran's supreme leader, said on Saturday that Tehran would block the initiative 'with or without Russia', with which Iran has a strategic alliance alongside Armenia. US President Donald Trump 'thinks the Caucasus is a piece of real estate he can lease for 99 years', Velayati told state-affiliated Tasnim News, referring to the transport corridor included in the peace deal. 'This passage will not become a gateway for Trump's mercenaries — it will become their graveyard,' he added, describing the plan as 'political treachery' aimed at undermining Armenia's territorial integrity. The terms of the accord, which was unveiled at a signing ceremony at the White House on Friday, include exclusive US development rights to a route through Armenia that would link Azerbaijan to Nakhchivan, an Azerbaijani enclave that borders Baku's ally Turkiye. The corridor, which would pass close to the border with Iran, would be named the Trump Route for International Peace and Prosperity, or TRIPP, and operate under Armenian law. Velayati argued that it would open the way for NATO to position itself 'like a viper' between Iran and Russia. Separately, Iran's foreign ministry issued a statement expressing concern about the negative consequences of any foreign intervention in the vicinity of its borders. While it welcomed the peace deal between Armenia and Azerbaijan, the ministry said any project near Iran's borders should be developed 'with respect for national sovereignty and territorial integrity, and without foreign interference'. For its part, Russia's Ministry of Foreign Affairs cautiously welcomed the deal, saying on Saturday that Moscow supported efforts to promote stability and prosperity in the region, including the Washington meeting. Similarly to Iran, however, it warned against outside intervention, arguing that lasting solutions should be developed by countries in the region. 'The involvement of non-regional players should strengthen the peace agenda, not create new divisions,' the ministry said, adding that it hoped to avoid the 'unfortunate experience' of Western-led conflict resolution in the Middle East. Meanwhile, Turkiye on Saturday said it hoped the planned transit corridor would boost exports of energy and other resources through the South Caucasus. A NATO member, Turkiye has strongly backed Azerbaijan in its conflicts with Armenia, but has pledged to restore ties with Yerevan after it signs a final peace deal with Baku. The Turkish presidency said President Recep Tayyip Erdogan discussed the peace agreement with Ilham Aliyev, his counterpart from Azerbaijan, and offered Ankara's support in achieving lasting peace in the region. Turkish Foreign Minister Hakan Fidan also addressed the planned corridor during a visit to Egypt, saying it could 'link Europe with the depths of Asia via Turkiye' and would be 'a very beneficial development'. Armenia and Azerbaijan have fought a series of wars since the late 1980s when Nagorno-Karabakh, a region in Azerbaijan that had a mostly ethnic Armenian population at the time, broke away from Azerbaijan with support from Armenia. Armenia last year agreed to return several villages to Azerbaijan in what Baku described as a 'long-awaited historic event'. Ahmad Shahidov, of the Azerbaijan Institute for Democracy and Human Rights, told Al Jazeera that he expected a final peace declaration between Armenia and Azerbaijan to be signed in the coming weeks. Shahidov said Friday's US-brokered deal constituted a 'roadmap' for the final agreement, which appears imminent given there are no unresolved territorial disputes between the two neighbours.


Qatar Tribune
3 hours ago
- Qatar Tribune
Trump and Putin to meet in Alaska for Ukraine talks next week
WASHINGTON: US President Donald Trump and Russian President Vladimir Putin will meet in Alaska next Friday to discuss the future of the war in Ukraine. Trump announced the 15 August meeting on social media and it was later confirmed by a Kremlin spokesperson, who said the location was "quite logical" given Alaska's relative proximity to Russia. There was no immediate reaction from Ukraine. The announcement of the meeting came just hours after Trump had signalled that Ukraine might have to cede territory in order to end the war, which began with Russia's full-scale invasion of its neighbour in February 2022. "You're looking at territory that's been fought over for three and a half years, a lot of Russians have died. A lot of Ukrainians have died," Trump said at the White House on Friday. "It's very complicated. We're going to get some back, we're going to get some switched. There will be some swapping of territories, to the betterment of both." The US president did not provide further details of what that proposal would look like.


Al Jazeera
10 hours ago
- Al Jazeera
How RFK Jr's vaccine funding cuts fit with Trump's vision
United States Health and Human Services Secretary Robert F Kennedy Jr has announced that the US is to cut funding for mRNA vaccine development – a move that health experts say is 'dangerous' and could make the US much more vulnerable to future outbreaks of respiratory viruses like COVID-19. Kennedy is known for his vaccine scepticism and recently ousted all 17 members of a scientific advisory panel on vaccines at the US Centers for Disease Control and Prevention (CDC) to be replaced with his own selections. However, this latest announcement is just part of a series of moves by President Donald Trump himself that appear to target the vaccine industry and give increasing weight to the arguments of vaccine sceptics in the US. Trump has previously undermined the efficacy of vaccines and sought to cut funding to vaccine programmes. Public health experts sounded the alarm after his election win in November, warning there would likely be a 'war on vaccines' under Trump. 'My main concern is that this is part of an increasingly ideological rather than evidence-based approach to healthcare and vaccination in particular that is being adopted in the US,' David Elliman, associate professor at University College London, told Al Jazeera. 'This is likely to increase vaccine hesitancy … [and] will result in more suffering and death, particularly for children. This would be a tragedy, even more so because it is avoidable.' What new cuts to vaccine funding have been made? In a statement posted on Tuesday on X, Kennedy said 22 projects on mRNA vaccine development worth nearly $500m will be cancelled. The main reason, he said, was that the Biomedical Advanced Research and Development Authority (BARDA) in his Department of Health and Human Services (HHS) had reviewed mRNA vaccines and found them to be 'ineffective' in fighting mutating viruses. 'A single mutation can make mRNA vaccines ineffective,' Kennedy said in a video statement. 'After reviewing the science and consulting top experts, … HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses.' Instead, Kennedy said, the US will shift mRNA funding to other vaccine development technologies that are 'safer' and 'remain effective'. Some notable institutions and companies that will be affected by the latest decision, as listed on the HHS website, include: Emory University and Tiba Biotech (terminated contracts) Pfizer, Sanofi Pasteur, CSL Seqirus (rejected or cancelled proposals) Luminary Labs, ModeX ('descoped' or weakened contracts) AstraZeneca and Moderna ('restructured' contracts) What are mRNA vaccines, and are they really ineffective against virus mutations? Messenger ribonucleic acid vaccines prompt the body to produce proteins that help it build immunity against certain microbes. They differ from traditional vaccines that introduce weakened or dead microbes into the body to stimulate immunity. Both types of vaccines have their strengths and weaknesses, but mRNA vaccines are notably faster to manufacture although they don't provide the lifelong coverage that traditional vaccines might. However, Elliman said virus mutations are a general problem for any vaccines and present a challenge scientists are still contending with. 'As yet, there are no vaccines in use that have solved this problem, so this is not a good reason for abandoning mRNA vaccines,' Elliman said. 'The technology has great promise for vaccines and therapeutics, so ceasing research in the field without good evidence is unjustified.' The move, he added, could discourage investors and scientists, both inside and outside the US, from keeping up research. Dorit R Reiss, a law professor at the University of California, San Francisco, who focuses on vaccine law, told Al Jazeera that the decision is 'troubling and shortsighted'. 'Procedurally, the decision was done in a very flawed manner. At the least, there should be notice and an opportunity for hearing and explanation under our administrative law, and there was instead a short and cursory X video with no references, no real data,' she said. The move will not only hurt innovation, she said, but will also leave the country less prepared for emergencies. What are RFK's views on vaccines? The health secretary has long been considered a vaccine sceptic. Kennedy formerly chaired Children's Health Defense – an anti-vaccine advocacy group formed in 2007 – until 2023 when he announced his run for the presidency. The organisation has also campaigned against the fortification of drinking water with fluoride, which prevents tooth decay. During a 2013 autism conference, Kennedy compared the CDC's childhood vaccine programme to Nazi-era crimes. 'To me, this is like Nazi death camps, what happened to these kids,' he said, referring to an increasing number of children diagnosed with autism. 'I can't tell you why somebody would do something like that. I can't tell you why ordinary Germans participated in the Holocaust.' In a 2023 interview with Fox News, Kennedy claimed vaccines cause autism. He cited a widely debunked study by Andrew Wakefield, a discredited British doctor and antivaccine activist whose study on the matter has since been retracted from journals. In another 2023 podcast, Kennedy said, 'No vaccine is safe or effective.' Aside from his vaccine scepticism, Kennedy, also known as RFK Jr, has also made several controversial remarks about other health issues, such as COVID-19. He criticised vaccine mandates and lockdown restrictions during the pandemic under former President Joe Biden. He also claimed in a leaked video in 2022 that COVID-19 'attacked certain races disproportionately' because of their genetic makeup and Ashkenazi Jews were most immune to the virus. Several research studies, however, found that social inequalities were major influences on how COVID-19 affected different ethno-social groups because certain people had reduced access to care. During a congressional hearing in the lead-up to his appointment in Trump's administration, Kennedy denied making several of the controversial statements attributed to him in the past. He also promised to maintain existing vaccine standards. What are Trump's views on vaccines? Trump has flip-flopped on this issue. He has previously downplayed the usefulness of vaccines and, in particular, criticised the schedules under which children receive several vaccine doses within their first two years. In his election campaign last year, Trump promised to dismantle vaccine mandates in schools. In a 2007 interview with the South Florida Sun-Sentinel, Trump claimed that an autism 'epidemic' had arisen as a result of vaccines, a theory which has since been debunked. 'My theory – and I study it because I have young children – my theory is the shots [vaccines]. We're giving these massive injections at one time, and I really think it does something to the children.' In subsequent interviews, Trump called childhood vaccines a 'monster shot' and in 2015 during a debate among Republican presidential candidates said vaccines were 'meant for a horse, not a child'. In 2015, he told a reporter he had never received a flu shot. But Trump has also spoken in favour of vaccines at times. During his first term as president, Trump said at a news briefing that children 'have to get their shots' after outbreaks of measles emerged across the country. 'The vaccinations are so important. This is really going around now,' he said. Additionally, in his first term during the COVID-19 pandemic, his administration initially downplayed the virus, but it ultimately oversaw the rapid production of COVID-19 vaccines in a project it called Operation Warp Speed. After Biden became president in 2021, Trump's camp criticised his vaccine and face mask mandates, which critics said contributed to rising levels of antivaccine sentiment among conservative voters. Trump also avoided using Operation Warp Speed's success as a selling point in last year's presidential campaign. He also did not publicly announce that he had received initial and booster COVID-19 vaccine shots before leaving the White House. Has the Trump administration targeted vaccines more broadly? During Trump's second term, the US introduced vaccine regulations that some critics said undermine the country's vaccine system. Furthermore, the Trump administration has cut funding to the US Agency for International Development, which supported hundreds of vaccine development programmes across the world. In February, Trump halted federal funding for schools that required students to have what his administration called 'coercive' COVID-19 vaccines. In May, Kennedy announced that the federal government would no longer recommend COVID-19 vaccines for healthy children and pregnant women without giving details about the reasons behind the change in policy. That went against the advice of US health officials who had previously urged boosters for young children. In June, Kennedy fired all 17 members of a CDC panel of vaccine experts, claiming that the board was 'rife with conflicts'. The panel, which had been appointed by Biden, was responsible for recommending how vaccines are used and for whom. Kennedy said the move would raise public confidence, stating that the US was 'prioritising the restoration of public trust above any specific pro- or antivaccine agenda. However, the move drew condemnation from scientists and health bodies. At the same time, the Food and Drug Administration, which also comes under the remit of the HHS, has approved at least one COVID-19 vaccine. In May, the FDA approved Novavax's non-mRNA, protein-based COVID-19 vaccine although only for older adults and those over the age of 12 who also have underlying health conditions that put them at higher risk from the virus. That was unusual for the US, where vaccines are usually approved without such limitations. The 2026 budget proposal to Congress does not include funding for the Global Vaccine Alliance (GAVI), a public-private entity formed in 2002 to support vaccine distribution to low and middle-income countries. GAVI was instrumental in securing vaccines for several countries in Africa and other regions during the COVID-19 pandemic when it was feared that richer countries could stockpile the available doses. The US currently provides more than 10 percent of GAVI's funding. In 2024, that amounted to $300m. Did Trump seek to undermine vaccine research and development during his first term as well? Yes. Trump's health budget proposals in 2018 and subsequently proposed budget cuts to the National Institute of Health and the CDC would have impacted immunisation programmes and a wide range of life-saving research on vaccines. However, the proposals were rejected by Congress. In May 2018, the Trump administration disbanded the Global Health and Biodefense Unit of the National Security Council. The team, which was set up to help prepare the US for pandemics and vaccine deployments, was formed in 2015 under President Barack Obama's administration during an Ebola epidemic. Later, when the COVID-19 pandemic reached the US, scientists blamed the country's vulnerability on Trump's decision.